Eur. Urol.

ISSN	1873-7560
ISSN-L	0302-2838
IUID	a45cfbfe764f48fd9f5c3d19510f106c
Modified	2020-11-27T13:14:07.655Z
Created	2017-05-09T09:12:52.013Z

Year 2022

PubMed DOI Crossref

Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients.

Welén K, Rosendal E, Freyhult E, ..., Överby AK, Josefsson A

Eur. Urol. 81 (6) e143-e144 [2022-06-00; online 2022-02-23]

Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative]

PubMed DOI Crossref

Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93.

Welen K, Rosendal E, Freyhult E, ..., Överby AK, Josefsson A

Eur. Urol. 81 (5) e124-e125 [2022-05-00; online 2022-02-12]

Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative]

Year 2021

PubMed DOI Crossref

A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data.

Welén K, Rosendal E, Gisslén M, ..., Överby AK, Josefsson A

Eur. Urol. - (-) - [2021-12-15; online 2021-12-15]

Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative]

PubMed DOI Crossref

Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.

Sjödahl G, Abrahamsson J, Holmsten K, ..., Ullén A, Liedberg F

Eur. Urol. - (-) - [2021-11-12; online 2021-11-12]

Clinical Genomics Lund [Service]

Year 2017

PubMed DOI Crossref

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.

De Laere B, van Dam PJ, Whitington T, ..., Grönberg H, Lindberg J

Eur. Urol. 72 (2) 192-200 [2017-08-00; online 2017-01-16]

Clinical Genomics Stockholm [Service]

Year 2015

PubMed DOI Crossref

Tracking the origin of metastatic prostate cancer.

Lindberg J, Kristiansen A, Wiklund P, Grönberg H, Egevad L

Eur. Urol. 67 (5) 819-822 [2015-05-00; online 2014-09-24]

NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

Year 2014

PubMed DOI Crossref

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.

Karlsson R, Aly M, Clements M, ..., Grönberg H, Wiklund F

Eur. Urol. 65 (1) 169-176 [2014-01-00; online 2012-07-20]

Mutation Analysis Facility (MAF)

Year 2013

PubMed DOI Crossref

The mitochondrial and autosomal mutation landscapes of prostate cancer.

Lindberg J, Mills IG, Klevebring D, ..., Egevad L, Grönberg H

Eur. Urol. 63 (4) 702-708 [2013-04-00; online 2012-12-26]

Karolinska High Throughput Center (KHTC) NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure

PubMed DOI Crossref

Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.

Lindberg J, Klevebring D, Liu W, ..., Egevad L, Grönberg H

Eur. Urol. 63 (2) 347-353 [2013-02-00; online 2012-04-17]

Karolinska High Throughput Center (KHTC) NGI Stockholm (Genomics Applications) NGI Stockholm (Genomics Production) National Genomics Infrastructure